Archives
Please, enter cell line, author or any other phrase or word you would like to search for.
Succeed in tracking your cells
We at PHI are always happy to hear from you, our customers, and receive feedback and suggestions on improving your HoloMonitor® experience. Therefore, we are excited to say that we have focused on realizing many of your suggestions with the latest software update, resulting in a new and advanced Single Cell Tracking analysis.
BioSpherix Partnership Yields HoloMonitor Customer in Regenerative Medicine
Recently, the EU-funded Centre for Innovative Medicine in Vilnius purchased its first HoloMonitor analyzer for use in the center’s incubator system from BioSpherix.
Harvard Researchers Purchase HoloMonitor
Partners HealthCare International in Boston, Massachusetts, recently ordered its first and fully equipped HoloMonitor unit.
Interim Report 3 (2020-11-01 – 2021-01-31)
The second wave of the pandemic restricted sales during the 3rd quarter. However, the situation has improved significantly since late January.
Can We Trust Our Cell-based Experiments?
Our 3-part webinar series explored in the fields of cancer research, stem cell research and for in vitro drug development, how relevant conditions lead to relevant answers in cell culture.
PHI Secure Working Capital Until 2023
PHI has received a second loan commitment of 20 MSEK. In total, the company has received loan commitments of 35 MSEK that are expected to secure the company’s working capital until 2023.
Introducing HoloMonitor M4
Get to know HoloMonitor M4 — an innovative, label-free live cell imaging and analysis system and its software App Suite!
Live Cell Imaging Videos
Live cell videos, imaged without labels, directly in an incubator by the HoloMonitor imaging system.
Live Cell Imaging Videos – The Best of 2020
What was your live cell video highlight this year? Vote now for your number one and let us know!
Interim Report 2 (2020-08-01 – 2020-10-31)
The relaxed COVID-19 restrictions during the 2nd quarter led to a noticeable increase in sales.